EPHA2 and hepatocellular carcinoma: For instance, ligand-bound EphA2 attenuated Erk activation in primary keratinocytes and hepatoma cells [30]; Ephrin-A/EphA signaling suppressed Erk activation induced by IGF-1 in myoblasts, facilitating myogenic differentiation [31].